ALUR

Allurion Technologies Inc. (NASDAQ:ALUR) is a medical device company founded to address the global obesity epidemic through innovative weight loss solutions. The company went public in March 2021 and is headquartered in Natick, Massachusetts. Allurion has developed a comprehensive weight loss platform centered around a swallowable, procedure-less intragastric balloon that aims to provide an alternative to traditional surgical and pharmaceutical weight loss interventions. The company has faced significant challenges in recent years, including regulatory setbacks, declining revenues, and substantial restructuring efforts as it works toward FDA approval in the United States while maintaining operations in international markets.